Related Experiment Video
Updated: Jan 19, 2026

Use of Ultra-high Field MRI in Small Rodent Models of Polycystic Kidney Disease for In Vivo Phenotyping and Drug Monitoring
Published on: June 23, 2015
Reduction in Heart Rate Variability in Autosomal Dominant Polycystic Kidney Disease
Silvia Lai1, Marco Mangiulli2, Adolfo M Perrotta2
1Nephrology Unit, Department of Translational and Precision Medicine, Sapienza University of Rome, Rome, Italy, silvia.lai@uniroma1.it.
Insights
Autonomic dysfunction, measured by heart rate variability (HRV), is reduced in autosomal dominant polycystic kidney disease (ADPKD) patients even with mild hypertension. This suggests increased cardiovascular risk in ADPKD patients beyond traditional factors.
Area of Science:
- Nephrology
- Cardiology
- Autonomic Neuroscience
Background:
- Cardiovascular disease is a primary cause of mortality in Autosomal Dominant Polycystic Kidney Disease (ADPKD).
- Autonomic dysfunction, assessed via heart rate variability (HRV), is linked to cardiovascular event risk in the general population.
Purpose of the Study:
- To compare HRV in ADPKD patients with mild hypertension against hypertensive patients with organ damage and healthy controls.
- To investigate autonomic nervous system function in ADPKD patients.
Main Methods:
- Enrolled 65 participants: 21 ADPKD patients, 20 hypertensive patients, and 24 healthy controls.
- Utilized biochemical analysis, clinical evaluation, anthropometric data, intima-media thickness, 24-h ECG Holter monitoring, and echocardiography.
Main Results:
- No significant HRV differences were observed between ADPKD patients and hypertensive patients.
- Global autonomic activity (SDNN) was significantly lower in both ADPKD and hypertensive patients compared to controls.
- Analysis revealed altered sympathovagal balance (LF/HF ratio) and sympathetic (LF) and parasympathetic (HF) activity during day and night in ADPKD and hypertensive patients versus controls.
Conclusions:
- Reduced HRV and altered sympathovagal balance are present in ADPKD patients with mild hypertension, even without overt organ damage.
- HRV assessment offers valuable insights into cardiovascular risk in ADPKD patients, complementing traditional risk factors.
Introduction:
Cardiovascular disease is one of the main causes of morbidity and mortality in patients with autosomal dominant polycystic kidney disease (ADPKD). Autonomic dysfunction is associated with an increased risk for all cardiovascular events in the general population and can be evaluated with heart rate variability (HRV).
Objective:
To evaluate HRV in ADPKD patients with mild hypertension versus hypertensive patients with organ damage and healthy controls (HC).
Materials And Methods:
We have enrolled 65 patients: 21 ADPKD patients (10 males), 20 patients with hypertension (14 males), and 24 HC (10 males). Biochemical analysis, clinical evaluation, anthropometric data, intima-media thickness, 24-h ECG Holter recording, and echocardiography were investigated at the time of enrollment.
Results:
No significant differences in HRV parameters were found between ADPKD with mild hypertension and hypertensive patients with organ damage. The median of HRV variables in time domain as SDNN (global autonomic activity) was significantly lower in ADPKD and hypertensive patients than HC (p < 0.05). In the frequency domain analysis, low frequency (LF), which mainly reflects the sympathetic component, showed higher values in ADPKD and hypertensive patients than HC during the night (p < 0.01). During the night, the sympathovagal balance, LF/high frequency (HF), showed higher values in ADPKD and hypertensive patients than HC (p < 0.0001). Conversely, LF day was lower in ADPKD and hypertensive patients than HC (p < 0.01). HF, which mainly reflects the parasympathetic component, was lower in ADPKD and hypertensive patients during the night than HC (p < 0.0001).
Conclusions:
HRV reduction is present in ADPKD patients with mild hypertension in the absence of organ damage. The evaluation of sympathovagal balance can provide novel information on the cardiovascular risk in ADPKD patients in addition to classical risk factors.
Related Concept Videos
Chronic Kidney Disease I: Introduction
Chronic Kidney Disease II: Clinical Manifestations
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Heart Failure Drugs: Diuretics
Cardiomyopathy II: Dilated Cardiomyopathy
Decreased pulse rate
There are specific risk factors that can elevate the likelihood of developing bradycardia. Advanced age is a significant factor, with...

